Patent application number | Description | Published |
20110260994 | SYSTEMS AND METHODS FOR DETERMINING THE LOCATION AND PRESSURE OF A TOUCHLOAD APPLIED TO A TOUCHPAD - A computing device with a multi-touch touch interface having a plurality of rows of contact points and a plurality of columns of contact points. For each other row of contact points, every contact point in the row is connected to form a row sensor. For each other column of contact points, every contact point in the column that is not part of a row sensor is connected to form a column sensor. The contact points that are not part of a row sensor and not part of a column sensor are connected together to form at least one shape sensor. A computing device with a multi-touch touch interface having a plurality of contact points has at least one layer of piezoresistive material, an insulating structure disposed between the plurality of contact points and the piezoresistive material, and a gap between the plurality of contact points and piezoresistive material. A method of providing multi-layered password recognition for a computing device having a touch interface first provides a passcode associated with an alphanumeric symbol to the computing device. The alphanumeric symbol is associated with a passcode pressure level. A touch load is applied to the touch interface and a measured pressure level associated with the applied touch load is determined. Then it is determined whether the measured pressure level corresponds to the passcode pressure level associated with the alphanumeric symbol of the passcode. | 10-27-2011 |
20140366650 | Pressure Mapping and Orientation Sensing System - This disclosure if directed to an improved pressure, force, and orientation sensing system, which may be applied to various industrial articles or sports equipment, fore remote performance analysis and user interface. Where applied to sports equipment, including a golf club, the sensor array of flexible and resilient piezo-resistive material permits collection of grip force data for an array of positions around and along the golf club grip handle; for the analysis, processing and communication of the data once collected, and a method of providing automated golf instruction using a force sensing golf grip of the present invention. Where applied to improved manufacturing lines and shipping of containers, force sensing packages may be equipped with the sensor arrays disclosed herein. The force sensing package is of similar shape to a standard sized package the ordinary forces on which are being tested and by the sampled force sensing package. Control and display software collects the force sensing data, and possibly other data (including motion and orientation data), and communicates it to analytics and display software remote from the device. The force sensing package is comprised of layers, at least two of the layers of which is a force sensing material and a related electrode array. Shapes disclosed are cylinders (cans), cylinders with conic portions (bottle), and parallelepipeds (boxes). | 12-18-2014 |
Patent application number | Description | Published |
20100095380 | DETECTION OF UNDESIRED COMPUTER FILES IN DAMAGED ARCHIVES - Systems and methods for an anti-virus detection module that can detect known undesired computer files in damaged archives that may be encrypted, compressed and/or password-protected are provided. According to one embodiment, a damaged archive file is received. And, without decrypting or decompressing the contents, an anti-virus detection module identifies a type and associated structure of the archive file by assuming each possible archive file type in turn and searching the archive file for descriptive information consistent with a current archive file type. Based thereon, descriptive information is obtained from the archive file describing one or more contained files within the archive file. Then, the descriptive information for each contained file is evaluated to determine if any contained files are malicious or undesired computer files. Finally, an attempt is made to prevent contained files determined to be a malicious or undesired computer file from being opened. | 04-15-2010 |
20110016530 | DETECTION OF UNDESIRED COMPUTER FILES IN ARCHIVES - Systems and methods that can detect known undesired computer files in protected archives are provided. According to one embodiment, an archive file in transit across a network as an attachment to an email message destined for a client workstation is scanned, without decrypting or decompressing contents of the archive, by an anti-virus detection module running on a network gateway. A type and associated structure of the archive are identified by examining primary or secondary identification bytes of the archive. Based on the type and structure, descriptive information regarding a contained file is obtained. The descriptive information includes a hash value of the contained file in uncompressed format. If the descriptive information matches a signature of a known undesired computer file, then a clean version of the archive is produced by removing the contained file and regenerating the archive. Finally, the clean version of the archive is delivered. | 01-20-2011 |
20110023121 | DETECTION OF UNDESIRED COMPUTER FILES IN DAMAGED ARCHIVES - Systems and methods for an anti-virus detection module that can detect known undesired computer files in damaged archives that may be encrypted, compressed and/or password-protected are provided. According to one embodiment, a damaged or incomplete RAR, CAB or ZIP archive is received. Without decrypting or decompressing the contents, an anti-virus detection module identifies the archive as a RAR, CAB or ZIP archive by assuming each of multiple possible archive types in turn and searching all of or certain parts of the archive for content consistent with a current archive type. Based on the identified type, for each contained file, descriptive information is extracted from corresponding local file headers and a threat evaluation is performed by comparing the descriptive information to signatures of known malicious or undesired files. If the treat evaluation concludes a particular contained file is a threat, then appropriate defensive actions are taken in relation to the archive. | 01-27-2011 |
20120090031 | DETECTION OF UNDESIRED COMPUTER FILES IN ARCHIVES - Systems and methods for content filtering are provided. According to one embodiment, a self-extracting archive is received with an electronic mail (email) message. Prior to delivery of the email message, a determination is made regarding whether a file contained in the archive may be malicious or undesired. A type of archive and associated structure of the archive are determined by examining identification bytes stored within a header portion of the archive that identify the type of archive. Based on the type and associated structure, for each contained file, descriptive information, including a checksum of the file in uncompressed form, a size of the file in uncompressed form and/or a size of the file in the compressed form, is extracted from the header portion. A file is identified as potentially malicious or undesired when the descriptive information matches a detection signature of a known malicious or undesired file. | 04-12-2012 |
20130104235 | DETECTION OF UNDESIRED COMPUTER FILES IN ARCHIVES - Systems and methods for content filtering are provided. According to one embodiment, a type and structure of an archive file are determined. The archive file includes identification bytes that identify the type of archive file and header information both in unencrypted and uncompressed form and a file data portion containing contents of files in encrypted form, compressed form or both. The determination is based solely on the identification bytes and/or the header information. Based thereon, descriptive information, describing characteristics of the files, is extracted from the header information for each file. The descriptive information includes a checksum of the file in uncompressed form, a size of the file in uncompressed form and/or a size of the file in compressed form. A file is identified as being potentially malicious or undesired when a comparison of the descriptive information to detection signatures of known malicious or undesired files results in a match. | 04-25-2013 |
Patent application number | Description | Published |
20090082751 | Device for transferring fluid from a cartridge to a container - A system and method for transferring a fluid from a first container to a second container, the system comprising a first container ( | 03-26-2009 |
20090308895 | Rack and pinon drive for by-pass cartridge - A device for mixing a substance comprised of two constituents contained in a cartridge and having a cartridge holder thereabout, the device comprising a plunger rod for pushing the closure member to permit the transfer of a diluent in a first chamber through a by-pass channel to mix with a constituent in a first chamber, the plunger rod being driven by means of a rack and a pinion gear arrangement to prevent overly rapid movement of the plunger rod. | 12-17-2009 |
20100042071 | Airless mixing with a by-pass syringe - A method for transferring and mixing a pharmaceutical mixture utilizing a by-pass cartridge and a syringe. After mixing the dry component and the diluent in the by-pass cartridge, the mixture can be passed to a syringe which includes a syringe plunger having a fluid passageway therein with a hydrophobic membrane covering the passageway. The mixture can be transferred back and forth between the by-pass cartridge and the syringe through a small bore to achieve mixing, particularly in the case of microspheres held in suspension. | 02-18-2010 |
20100258213 | Transfer device - The transfer device for transferring a fluid from a container having a body with an open first end and a piston within the body, the transfer device comprising an outer housing which is designed to receive a cartridge assembly which includes the container, the plunger rod aligned with the piston in the body, a spring position to drive the plunger rod in a direction towards the piston, a retractor to move the plunger rod from an activated position wherein the spring is extended to a non-activated position wherein the spring is compressed, and an actuator to permit the spring to be released to drive the plunger rod to move the piston within the container body. Typically, the device is used for transferring fluid from one container to a further container. | 10-14-2010 |
20110068124 | RACK AND PINION DRIVE FOR BY-PASS CARTRIDGE - A device for mixing a substance comprised of two constituents contained in a cartridge ( | 03-24-2011 |
20110106021 | Device and Method for Topical Application of Therapeutics or Cosmetic Compositions - This invention relates to devices and methods for safely reconstituting and administering topical therapeutic or cosmetic compositions. The topical applicator according to the invention is particularly well suited for storing, reconstituting, and administering or applying highly toxic substances. | 05-05-2011 |
20110106045 | Inter vial transfer system - A transfer system suitable for medicaments comprising a vial socket, a housing having first and second open ends with the first open end being releasably connected to the vial socket, a needle hub mounted within the housing, a needle having first and second piercing ends mounted in the needle hub, a vial having a neck and a body, the vial being inserted in the vial socket and being non removably retained therein, a cartridge having a plunger sealing an open end thereof and a septum located at an opposite end of the cartridge, and an activation cap for causing the needle to penetrate a septum of the vial and the septum of the cartridge to permit transfer of components therebetween. | 05-05-2011 |
20120238969 | Device and Method for Topical Application of Therapeutics or Cosmetic Compositions - This invention relates to devices and methods for safely reconstituting and administering topical therapeutic or cosmetic compositions. The topical applicator according to the invention is particularly well suited for storing, reconstituting, and administering or applying highly toxic substances. | 09-20-2012 |
20130018324 | INJECTION DEVICEAANM Reynolds; David L.AACI BromontAACO CAAAGP Reynolds; David L. Bromont CAAANM MacDonald; DanielAACI BromontAACO CAAAGP MacDonald; Daniel Bromont CAAANM Tremblay; YanAACI OrfordAACO CAAAGP Tremblay; Yan Orford CAAANM Trepanier; JulieAACI SherbrookeAACO CAAAGP Trepanier; Julie Sherbrooke CA - An injection device ( | 01-17-2013 |
20140000738 | EASY LINKING TRANSFER SYSTEM | 01-02-2014 |
Patent application number | Description | Published |
20090088404 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine - Extended release formulations of S-methyladenosylmethionine (SAMe) are provided, as are methods of treating various disorders using extended release SAMe formulations. The extended release formulations may be used to treat a variety of disorders, including liver disorders, psychiatric disorders and joint disorders. Thus, extended release SAMe formulations may be used to treat alcoholic liver disease, fatty liver disease, hepatitis, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, and depressive disorders such as depression (e.g. major clinical depression) and dysthymia. | 04-02-2009 |
20090197824 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine - Extended release formulations of S-methyladenosylmethionine (SAMe) are provided, as are methods of treating various disorders using extended release SAMe formulations. The extended release formulations may be used to treat a variety of disorders, including liver disorders, psychiatric disorders and joint disorders. Thus, extended release SAMe formulations may be used to treat alcoholic liver disease, fatty liver disease, hepatitis, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, and depressive disorders such as depression (e.g. major clinical depression) and dysthymia. | 08-06-2009 |
Patent application number | Description | Published |
20100152185 | DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - The instant invention provides compounds of formula I which are 5-lipoxygenase activating protein inhibitors. | 06-17-2010 |
20110053940 | 3,4-SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS - The present invention relates to 3,4-substituted piperidinyl-based renin inhibitor compounds bearing at 4-position oxopyridine and having the formula (I). The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency. | 03-03-2011 |
20110152316 | 3,4-SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS - The present invention relates to 3,4-substituted piperidinyl-based renin inhibitor compounds bearing at 4-position Isoqumolone and having the Formula (I): The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency. | 06-23-2011 |
20110237541 | TRANSDERMALLY ADMINISTERED ALISKIREN - Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a desired therapeutic effect. Use of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving a desired therapeutic effect. Method for achieving a desired therapeutic effect by transdermal administration of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s). | 09-29-2011 |
20120035214 | RENIN INHIBITORS - The present invention relates to biaryl piperidine-based renin inhibitor compounds, and their use in treating cardiovascular events and renal insufficiency. | 02-09-2012 |
20120046293 | RENIN INHIBITORS - The present invention relates to renin inhibitor compounds having the structure | 02-23-2012 |
Patent application number | Description | Published |
20090075878 | Methods for Generating and Screening Fusion Protein Libraries and Uses Thereof - The invention provides methods for generating fusion protein libraries, such as immunotoxin libraries. The invention also relates to libraries of recombinant cells encoding nucleic acid sequences comprising fusion proteins. In addition, the invention relates to the libraries themselves and the use of the libraries to screen for fusion proteins that are specific for target cells, such as cancer cells. Further, the invention relates to methods of improving fusion proteins and to the improved fusion proteins. | 03-19-2009 |
20090305972 | NOVEL CANCER-ASSOCIATED ANTIGEN - The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immuno-conjugates. The invention also relates to diagnostic and therapeutic methods and kits. | 12-10-2009 |
20100215670 | Immunotoxin Fusions Comprising An Antibody Fragment and a Plant Toxin Linked by Protease Cleavable Linkers - Novel conjugates are disclosed which comprise (a) a ligand that binds to a surface molecule on a target cell, such as a cancer cell; (b) an effector molecule that is to be delivered into the cell, such as a toxin; and (c) a linker sequence that couples the ligand and the effector molecule wherein the linker comprises at least one protease cleavage site corresponding to a protease found in the intracellular trafficking pathway of the effector molecule; wherein the cleavage of the linker by the protease uncouples the effector molecule from the ligand. | 08-26-2010 |
20100267086 | Optimized Nucleic Acid Sequences For The Expression of VB4-845 - An optimized nucleic acid sequence encoding the immunoconjugate VB4-845 is disclosed. Modifications to the original VB4-845 nucleic acid sequence include optimization of the sequences encoding the V | 10-21-2010 |
20120058106 | NOVEL CANCER-ASSOCIATED ANTIGEN - The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits. | 03-08-2012 |
20130243799 | NOVEL CANCER-ASSOCIATED ANTIGEN - The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits. | 09-19-2013 |
Patent application number | Description | Published |
20100145023 | Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins - An optimized nucleic acid sequence encoding the immunoconjugate VB6-845 is described Modifications to the original VB6-845 include changes in the nucleic acid sequence encoding the V | 06-10-2010 |
20100254982 | CANCER SPECIFIC ANTIBODY AND CELL SURFACE PROTEINS - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof. | 10-07-2010 |
20120128723 | CANCER SPECIFIC ANTIBODY AND CELL SURFACE PROTEINS - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof. | 05-24-2012 |
20130217865 | Tumor Specific Antibody - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention. | 08-22-2013 |
Patent application number | Description | Published |
20110027342 | S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY - The invention relates to compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease. | 02-03-2011 |
20110027360 | PHARMACOKINETICS OF S-ADENOSYLMETHIONINE FORMULATIONS - Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning. | 02-03-2011 |
20130129792 | Pharmacokinetics of S-Adenosylmethionine Formulations - Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning. | 05-23-2013 |
20130142847 | S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY - Provided herein are compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. In certain embodiments, the enhanced bioavailability formulations provided herein may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease. | 06-06-2013 |
20130149350 | Pharmacokinetics of S-Adenosylmethionine Formulations - Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning. | 06-13-2013 |
20140220129 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester - Provided herein are compositions and formulations comprising S-adenosyl-L-methionine (“SAM-e” or “SAMe”) and one or more gallic acid esters. Also provided herein are methods for improving the delivery of SAMe. Compositions and formulations provided herein increase SAMe plasma concentrations and area under the curve (AUC) values. Also provided herein are methods of treating a disease or disorder in a subject by administering compositions or formulations comprising exogenous SAMe and one or more gallic acid esters. | 08-07-2014 |
20140370108 | Pharmacokinetics of S-Adenosylmethionine Formulations - Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning. | 12-18-2014 |
Patent application number | Description | Published |
20090242467 | System that removes contaminants from sulfur - A system for removing contaminant from sulfur to a level that allows re-processed sulfur to reenter a supply chain. The system melts contaminated sulfur, filters the molten sulfur, and then dispenses the less contaminated sulfur after filtering it. More specifically, solid contaminated sulfur enters a settling tank, while heated molten sulfur circulates through the system and the settling tank. The circulation of the molten sulfur assists in the melting process of the solid sulfur, allowing the solid sulfur to melt efficiently. In preferred embodiments of the system, the system uses steam jacked sulfur lines and steam tracing to maintain temperatures for melting the solid sulfur and maintaining the molten state of the sulfur circulating through the system. Furthermore, the system comprises a programmable logic controller, which controls motors, pumps, valves, and environment monitoring instruments. | 10-01-2009 |
20110271490 | SYSTEM AND METHOD THAT REMOVES CONTAMINANTS FROM SULFUR - A system and method for removing contaminant from sulfur (or sulphur) to a level that allows re-processed sulfur to reenter a supply chain. The system and method melt contaminated sulfur, filters the molten sulfur, and then dispenses the less contaminated sulfur after filtering it. More specifically, solid contaminated sulfur enters a settling tank, while heated molten sulfur circulates through the system and the settling tank. The circulation of the molten sulfur assists in the melting process of the solid sulfur, allowing the solid sulfur to melt efficiently. In preferred embodiments of the system, the system uses steam jacked sulfur lines and steam tracing to maintain temperatures for melting the solid sulfur and maintaining the molten state of the sulfur circulating through the system. Furthermore, the system comprises a programmable logic controller, which controls motors, pumps, valves, and environment monitoring instruments. | 11-10-2011 |
Patent application number | Description | Published |
20080214360 | METHOD AND APPARATUS FOR ESTIMATING A MOTION PARAMETER - A system for estimating motion parameters corresponding to a user. The system may generally include a receiver operable to receive a signal from an external source, an inertial sensor operable to be coupled with the user and arbitrarily oriented relative to the direction of user motion for generation of a signal corresponding to user motion, and a processing system in communication with the receiver and inertial sensor. The processing system can be operable to utilize the receiver signal to estimate a first parameter corresponding to a first motion parameter type, utilize the inertial sensor signal to estimate a second parameter corresponding to a second motion parameter type, generate a user-specific motion model to correlate the first parameter type and second parameter type using at least the first and second estimated parameters, utilize the inertial sensor signal to estimate a third parameter corresponding to the second parameter type, and utilize the motion model and the third parameter to estimate a fourth parameter corresponding to the first parameter type independent of the receiver signal. | 09-04-2008 |
20090076765 | METHOD AND APPARATUS FOR ESTIMATING A MOTION PARAMETER - A method and apparatus for estimating a motion parameter corresponding to a subject element employs one or more accelerometers operable to measure accelerations and a processing system operable to generate a motion parameter metric utilizing the acceleration measurements and estimate the motion parameter using the motion parameter metric. | 03-19-2009 |
20090315127 | METHOD AND APPARATUS FOR IMPROVING MEASUREMENT ACCURACY OF MEMS DEVICES - A system for improving the performance of a microelectromechanical systems (MEMS) device that is housed in a package and implemented on a printed circuit board (PCB) comprises a footprint, an isolation channel, and a bridge. A portion of the isolation channel is removed to mechanically isolate the MEMS device. | 12-24-2009 |
20110022349 | METHOD AND APPARATUS FOR ESTIMATING A MOTION PARAMETER - A system for estimating motion parameters corresponding to a user. The system may generally include a receiver operable to receive a signal from an external source, an inertial sensor operable to be coupled with the user and arbitrarily oriented relative to the direction of user motion for generation of a signal corresponding to user motion, and a processing system in communication with the receiver and inertial sensor. The processing system can be operable to utilize the receiver signal to estimate a first parameter corresponding to a first motion parameter type, utilize the inertial sensor signal to estimate a second parameter corresponding to a second motion parameter type, generate a user-specific motion model to correlate the first parameter type and second parameter type using at least the first and second estimated parameters, utilize the inertial sensor signal to estimate a third parameter corresponding to the second parameter type, and utilize the motion model and the third parameter to estimate a fourth parameter corresponding to the first parameter type independent of the receiver signal. | 01-27-2011 |
20130151193 | METHOD AND APPARATUS FOR DETERMINING MOTION EXPLOSIVENESS - A method and apparatus for determining motion explosiveness is described herein. In some configurations, a system is provided that includes a display, an inertial sensor operable to generate signals corresponding to user motion; and a processing system in communication with the inertial sensor and the display. The processing system is operable to calculate a histogram representing the sensed user motion, the histogram providing an indication of motion explosiveness, and communicate with the display to present the indication of motion explosiveness on the display. | 06-13-2013 |
Patent application number | Description | Published |
20100186343 | Method for Installing Wall Panels to the Exterior Wall of a Building - A method for installing wall panels to an exterior building wall is provided. The method applies the rainscreen principle. Interlocking components are used to attach aluminum or other wall panels to an exterior wall. In one aspect, the method includes fastening a bracket assembly to the exterior building wall, fastening an attachment clip to the bracket assembly, providing a panel perimeter strip, providing a wall panel, fastening the wall panel to the panel perimeter strip along one side surface of the wall panel, providing a through-opening through the wall panel thereby permitting fluid communication from an atmosphere into the hollow interior portion of the wall panel, and sliding an infill strip into a slot of the panel perimeter strip between the attachment clip and the through opening so as to cover a fastener of the bracket assembly; The system is held together non-adhesively. | 07-29-2010 |
20100263314 | Dry Joint Wall Panel Attachment System - A dry joint wall panel attachment system is provided. The system uses interlocking components to attach aluminum (or other) wall panels to an exterior wall. The system is held together non-adhesively. | 10-21-2010 |
20120085042 | Wall Panel Systems for Rigid Wall Panels - Wall panel systems are provided. The systems use interlocking components to attach photovoltaic (PV), ceramic, or other rigid wall panels to an exterior wall of a building. | 04-12-2012 |
20120198788 | Method for Installing Wall Panels to the Exterior Wall of a Building - A method for installing wall panels to a wall of a building is provided. The method applies the rainscreen principle. Interlocking components are used to attach aluminum or other wall panels to an exterior wall. In one aspect, the method includes operatively connecting a plurality of attachment clips to a wall surface of the exterior building wall. The method also includes providing a first panel perimeter strip and a second panel perimeter strip. The first panel perimeter strip is fastened to a first wall panel along a first side surface of the first wall panel, while the second panel perimeter strip is fastened to a second wall panel along a first side surface of the second wall panel. The method then includes sliding the first panel perimeter strip onto a first wing member of an attachment clip, thereby connecting the first wall panel to the wall, and sliding the second panel perimeter strip onto a second opposing wing member of the attachment clip, thereby connecting the second wall panel to the wall. In this way, the first side surfaces of the first and second wall panels are adjacent. The attachment clips and the panel perimeter strips represent a wall panel attachment system that is held together non-adhesively. Of significance, the system is configured to allow wall panels to be secured to a wall in any sequence or direction. | 08-09-2012 |
Patent application number | Description | Published |
20110050158 | System for storing electrical energy - A method and apparatus are described for storing electrical power in the form of relative chemical potential between a concentrated solution, typically salt brine, and a dilute version of the same solution. To recover the power, the concentrated solution and dilute solution are supplied to a means for transforming the difference in their chemical potential into electrical power by such means as pressure retarded osmosis or reverse electrodialysis. In operation such means take in the concentrated and dilute solutions and exhaust a solution of intermediate concentration. The concentrated solution is supplied from a container such as a pond. It is generated by evaporation of the intermediate concentration solution in a second, separate pond, which receives the exhaust from the power generation means. The exhaust solution is concentrated by evaporation and is transferred into the first pond when the concentration has reached a sufficient level. To obtain a high evaporation rate in a relatively small evaporation area, the evaporation is enhanced to a rate faster than that obtained at the liquid surface of an open pond of the solution by employing electrical evaporation enhancement means. The electrical evaporation enhancement means is programmed to draw power from an electrical supply grid during periods when electricity demand is low and or when the cost of electricity is below or equal to an average cost over a period such as a diurnal cycle. When demand is high the enhancement is discontinued and the power generation means uses the stored concentrated brine to generate extra electrical power. Therefore the enhancement means would be used less than 30% of the time when the stored concentrated brine is being used to generate electrical power. | 03-03-2011 |
20110086250 | METHOD AND APPARATUS FOR STORING ELECTRICAL POWER BY EVAPORATING WATER - Electrical energy is stored in a concentrated solution. To recover the energy, the concentrated solution is rediluted for example by pressure retarded osmosis. The concentrated solution is generated by evaporation of the exhaust solution from the energy recovery process. The evaporation is enhanced by electrically powered enhancement means and the corresponding electrical input constitutes the power to be stored. The enhanced evaporation also draws heat from the environment, whereby the input electrical energy is augmented, partially or completely offsetting inefficiencies in the system. In grid applications, when demand for electricity is high the enhancement is discontinued and power is generated from the stored concentrated brine. Alternatively the evaporation enhancement may draw power from a power source that does not operate continuously, such as a renewable energy source. The stored brine is employed to generate power during periods when the renewable energy source falls below a predetermined power supply capability. | 04-14-2011 |
20110204841 | System for storing electrical energy - A method and apparatus are described for storing electrical power in the form of relative chemical potential between a concentrated solution, typically salt brine, and a dilute version of the same solution. To recover the power, the concentrated solution and dilute solution are supplied to a means for transforming the difference in their chemical potential into electrical power by such means as pressure retarded osmosis or reverse electrodialysis. In operation such means take in the concentrated and dilute solutions and exhaust a solution of intermediate concentration. The concentrated solution is supplied from a container such as a pond. It is generated by evaporation of the intermediate concentration solution in a second, separate pond, which receives the exhaust from the power generation means. The exhaust solution is concentrated by evaporation and is transferred into the first pond when the concentration has reached a sufficient level. To obtain a high evaporation rate in a relatively small evaporation area, the evaporation is enhanced to a rate faster than that obtained at the liquid surface of an open pond of the solution by employing electrical evaporation enhancement means. The electrical evaporation enhancement means is programmed to draw power from an electrical supply grid during periods when electricity demand is low and or when the cost of electricity is below or equal to an average cost over a period such as a diurnal cycle. When demand is high the enhancement is discontinued and the power generation means uses the stored concentrated brine to generate extra electrical power. Therefore the enhancement means would be used less than 30% of the time when the stored concentrated brine is being used to generate electrical power. | 08-25-2011 |
Patent application number | Description | Published |
20080305147 | Drug Delivery System For The Prevention Of Cerebral Vasospasm - The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm. | 12-11-2008 |
20110142937 | Methods and Compositions To Treat Hemorrhagic Conditions of The Brain - The described invention provides a nonhuman animal model system for hemorrhagic brain conditions, methods for evaluating a substance for treating the hemorrhagic brain condition in a mammal, methods for treating hematoma expansion or recurrent rebleeding resulting from hemorrhagic brain conditions in a mammal, and pharmaceutical compositions for administration into or at a distance proximal to the hemorrhagic brain condition. | 06-16-2011 |
20120164226 | Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage - The described invention provides a pharmaceutical composition, delivery system and a method for treating a delayed complication associated with a brain injury in a mammal and improving its prognosis in a mammal by implanting a therapeutically effective amount of the pharmaceutical composition containing a voltage-gated calcium channel blocker and a pharmaceutically acceptable carrier into a predetermined location in the brain, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 06-28-2012 |
20120245561 | INTRAVENTRICULAR DRUG DELIVERY SYSTEM FOR IMPROVING OUTCOME AFTER A BRAIN INJURY AFFECTING CEREBRAL BLOOD FLOW - The described invention provides a flowable sustained release microparticulate composition, a kit for treating at least one cerebral artery in a subarachnoid space at risk of interruption due to a brain injury, a method of preparing the composition, and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 09-27-2012 |
20120308658 | METHODS AND COMPOSITIONS TO TREAT HEMORRHAGIC CONDITIONS OF THE BRAIN - The described invention provides a nonhuman animal model system for hemorrhagic brain conditions, methods for evaluating a substance for treating the hemorrhagic brain condition in a mammal, methods for treating hematoma expansion or recurrent rebleeding resulting from hemorrhagic brain conditions in a mammal, and pharmaceutical compositions for administration into or at a distance proximal to the hemorrhagic brain condition. | 12-06-2012 |
20130022660 | DRUG DELIVERY SYSTEM FOR THE PREVENTION OF CEREBRAL VASOSPASM - The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm. | 01-24-2013 |
20130243864 | COMPOSITIONS AND THEIR USE TO TREAT COMPLICATIONS OF ANEURYSMAL SUBARACHNOID HEMORRHAGE - The described invention provides a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury using a flowable sustained release particulate composition. | 09-19-2013 |
20130302431 | Polymorph Compositions, Methods of Making, and Uses Thereof - The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 11-14-2013 |
20140271895 | Polymorph Compositions, Methods of Making, and Uses Thereof - The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 09-18-2014 |
Patent application number | Description | Published |
20100186343 | Method for Installing Wall Panels to the Exterior Wall of a Building - A method for installing wall panels to an exterior building wall is provided. The method applies the rainscreen principle. Interlocking components are used to attach aluminum or other wall panels to an exterior wall. In one aspect, the method includes fastening a bracket assembly to the exterior building wall, fastening an attachment clip to the bracket assembly, providing a panel perimeter strip, providing a wall panel, fastening the wall panel to the panel perimeter strip along one side surface of the wall panel, providing a through-opening through the wall panel thereby permitting fluid communication from an atmosphere into the hollow interior portion of the wall panel, and sliding an infill strip into a slot of the panel perimeter strip between the attachment clip and the through opening so as to cover a fastener of the bracket assembly; The system is held together non-adhesively. | 07-29-2010 |
20100263314 | Dry Joint Wall Panel Attachment System - A dry joint wall panel attachment system is provided. The system uses interlocking components to attach aluminum (or other) wall panels to an exterior wall. The system is held together non-adhesively. | 10-21-2010 |
20120085042 | Wall Panel Systems for Rigid Wall Panels - Wall panel systems are provided. The systems use interlocking components to attach photovoltaic (PV), ceramic, or other rigid wall panels to an exterior wall of a building. | 04-12-2012 |
20120186170 | Wall Panel Systems for Rigid Wall Panels - Wall panel systems are provided. The systems use interlocking brackets to attach photovoltaic (PV), ceramic, or other rigid wall panels to an exterior wall of a building. The interlocking components include a plurality of wall mounting brackets configured to carry the dead loads of the respective wall panels, and a plurality of panel brackets that may be quickly hung from the wall mounting brackets. The wall mounting brackets are configured to be operatively fastened to an exterior wall surface, while each of the panel brackets is adhesively attached to the rear surface of a respective panel. Each of the wall mounting brackets and the nested panel brackets is substantially similar in dimension and configuration. Further, the system is configured to allow wall panels to be attached to the bracket assemblies in any sequence. A method for attaching architectural wall panels is also provided herein. | 07-26-2012 |
20120198788 | Method for Installing Wall Panels to the Exterior Wall of a Building - A method for installing wall panels to a wall of a building is provided. The method applies the rainscreen principle. Interlocking components are used to attach aluminum or other wall panels to an exterior wall. In one aspect, the method includes operatively connecting a plurality of attachment clips to a wall surface of the exterior building wall. The method also includes providing a first panel perimeter strip and a second panel perimeter strip. The first panel perimeter strip is fastened to a first wall panel along a first side surface of the first wall panel, while the second panel perimeter strip is fastened to a second wall panel along a first side surface of the second wall panel. The method then includes sliding the first panel perimeter strip onto a first wing member of an attachment clip, thereby connecting the first wall panel to the wall, and sliding the second panel perimeter strip onto a second opposing wing member of the attachment clip, thereby connecting the second wall panel to the wall. In this way, the first side surfaces of the first and second wall panels are adjacent. The attachment clips and the panel perimeter strips represent a wall panel attachment system that is held together non-adhesively. Of significance, the system is configured to allow wall panels to be secured to a wall in any sequence or direction. | 08-09-2012 |
Patent application number | Description | Published |
20080214417 | Lubricant for wear testing of joint replacements and associated materials - The present invention relates to an artificial synovial fluid composition that mimics the tribological properties of human, osteoarthritic synovial fluid (SF) for the main purpose of in vitro wear testing. There is described an artificial synovial fluid composition comprising: a) a mammalian serum having i) a total protein concentration of from about 10 to about 45 g/L; ii) an albumin fraction of from about 55% to about 80% w/w %; iii) an α-1 globulin fraction of from about 3% to about 6% w/w %; iv) an α-2 globulin fraction of from about 5% to about 10% w/w %; v) a β-globulin fraction of from about 3% to about 20% w/w %; vi) a γ-globulin fraction of from about 5% to about 20% w/w %; vii) a calcium (Ca) concentration of from about 0.1 mmol/L to about 3 mmol/L; viii) a magnesium (Mg) concentration of from about 0.05 mmol/L to about 0.8 mmol/L; ix) an inorganic phosphate (P) concentration of from about 0.1 mmol/L to about 1.5 mmol/L; x) an iron (Fe) concentration of from about 0.001 mmol/L to about 0.1 mmol/L; xi) a peptide concentration at a 2,000 Da molecular weight cut-off of from about 0.005 g/L to about 10 g/L; xii) a maximal transition midpoint temperature, T | 09-04-2008 |
20120266699 | LUBRICANT FOR WEAR TESTING OF JOINT REPLACEMENTS AND ASSOCIATED MATERIALS - The present invention relates to an artificial synovial fluid composition that mimics the tribological and biochemical properties of human, osteoarthritic synovial fluid for in vitro testing of implantable materials. The artificial synovial fluid comprises new-born calf serum or alpha-calf serum (iron-free or iron-supplemented) that contains a specific total protein concentration, specific protein constituent fractions (albumin, α-1 globulin, α-2 globulin, β-globulin, and γ-globulin), specific trace element concentrations (Ca, Mg, inorganic P, and Fe), and a specific low-molecular weight peptide concentration important for in vitro testing of implantable materials. In addition, the artificial synovial fluid contains a hyaluronic acid concentration and level of osmolality (preferably using phosphate buffered-saline solution) to mimic the thermal stability (transition mid-point temperature, enthalpy, and entropy) and pH level as measured clinically. | 10-25-2012 |
Patent application number | Description | Published |
20110315683 | PAINT CONTAINER COVER - A paint container cover is provided. The paint container cover comprises a lid portion enabled for removable attachment to a top of a paint can. The paint container cover further comprises at least one sealable opening in the lid portion for receiving a handle of a paint brush extending from the paint can such that the handle can extend from the top of the paint can through the sealable opening, the sealable opening enabled to prevent air from entering the paint can when the lid portion is attached thereto and the handle is extending through the sealable opening. | 12-29-2011 |
20110315700 | PAINT CAN STRAP AND HOLDER - Paint can straps and holders releasably attachable to a paint can are provided, such that at least one of fingers, a hand, forearm, and an arm can be inserted between a strap portion and the paint can, and along a longitudinal axis of the paint can, to leverage the paint can. The paint can holder includes a strap that is releasably attachable to the paint can. The strap can be attached to a harness, which is releasably attachable to the paint can. The harness can include a paint brush holder which can also be provided independent of the harness. | 12-29-2011 |
20120002904 | PAINT TRAY BAG WITH EXTENDED DROP SHEET - A paint tray bag is provided. The paint tray bag comprises a bag comprising dimensions for containing a paint tray, and optionally painting tools, therein. The paint tray bag further comprises a sealing apparatus for releasably sealing the bag, the sealing apparatus around at least portion of a perimeter of the bag such that the bag comprises a closed position for containing the paint tray therein when the sealing apparatus is closed and an open position when the sealing apparatus is open, the bag enabled to lay flat in the open position to act as a drop sheet for the paint tray. The paint tray bag further comprises an extended drop sheet which unfolds from the bag to provide an extended area for the drop sheet. | 01-05-2012 |
20120228331 | MODULAR PAINT SPOUT - A point spout is provided. The paint spout comprises a hollow spout shaft comprising an insertion end and an oppositely disposed pouring end, the insertion end enabled for removable attachable insertion into a hole of a paint container, the pouring end enabled to direct paint pouring through the hollow spout shaft. The paint spout further comprises a strainer retaining portion at an interior surface of the hollow spout shaft for retaining a strainer member enabled for removable attachment to the interior surface of the hollow spout shaft such that the paint poured there through is filtered by the strainer member. | 09-13-2012 |
20120325858 | MODULAR PAINT SPOUT - A paint spout is provided comprising: a hollow spout shaft comprising an insertion end and an oppositely disposed pouring end, the insertion end enabled for removable attachable insertion into a hole of a paint container, the pouring end enabled to direct paint pouring, through the hollow spout shaft; a strainer member; and, a strainer retaining portion for enabling a strainer member to be removably retained by the hollow spout shaft such that the paint poured there through is filtered by the strainer member, wherein the strainer member extends from at least one of: the pouring end of the hollow spout shaft; and, the insertion end of the hollow spout shaft. | 12-27-2012 |
20130087478 | PAINT TRAY BAG - A paint tray bag is provided. The paint tray bag comprises a bag comprising dimensions for containing a paint tray, and optionally painting tools, therein. The paint tray bag further comprises a sealing apparatus for releasably sealing the bag, the sealing apparatus around at least portion of a perimeter of the bag such that the bag comprises a closed position for containing the paint tray therein when the sealing apparatus is closed and an open position when the sealing apparatus is open, the bag enabled to lay flat in the open position to act as a drop sheet for the paint tray. | 04-11-2013 |
20140175104 | PAINT BUCKET COVER - An apparatus that is generally directed to a paint bucket cover, and specifically to a sealable paint bucket cover comprising structures to securely hold painting tools such as rollers or brushes within the container when the cover is in place, is provided. When not being accessed, paint containers need to be sealed to keep the contents from spilling, or the paint from drying out. Frequently, however, it desirable to be able to cover a paint container while painting tools are still in the bucket. The cover includes a panel comprised of at least a first surface and a paint tool holder, and a band for releasably connecting the cover to the paint container while creating a substantially air-tight configuration. | 06-26-2014 |